Sai Ravi Pingali, MD

Associate Professor of Clinical Medicine in Oncology, Academic Institute
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Pingali is board certified by the American Board of Internal Medicine in medical oncology and hematology. His primary focus is on hematologic malignancies and stem cell transplantation. After completing his medical training in India, Dr. Pingali received training in various reputable programs in the United Kingdom as part of senior house officer training after which he moved to the United States. He completed his residency in internal medicine at Gundersen Lutheran Medical Center in Wisconsin. He then completed a fellowship in hematology and oncology at the Medical College of Wisconsin, and a fellowship in stem cell transplantation at the University of Texas MD Anderson Cancer Center.

Dr. Pingali is a member of the American Society of Clinical Oncology, American Society of Hematology and the American Society for Blood and Marrow Transplantation. He sees patients at Houston Methodist Hospital.

Publications

G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
Youssef, JG, Zahiruddin, F, Youssef, G, Padmanabhan, S, Ensor, J, Pingali, SR, Zu, Y, Sahay, S & Iyer, SP 2021, , Annals of Hematology, vol. 100, no. 3, pp. 667-673. https://doi.org/10.1007/s00277-021-04395-1

Yeni jenerasyon proteozom inhibitörleriyle olan çevresel nöropati yükünün fda yan etki raporlama sistemi kullanilarak pazarlama sonrasi analizi
Mina, SA, Muhsen, IN, Burns, EA, Sarfraz, H, Pingali, SR, Xu, J & Hashmi, SK 2021, , Turkish Journal of Hematology, vol. 38, no. 3, pp. 218-221. https://doi.org/10.4274/tjh.galenos.2021.2021.0052

Primary cutaneous anaplastic large-cell lymphoma: a review of the SEER database from 2005 to 2016
Sarfraz, H, Gentille, C, Ensor, J, Wang, L, Wong, S, Ketcham, MS, Joshi, J & Pingali, SRK 2021, , Clinical and Experimental Dermatology, vol. 46, no. 8, pp. 1420-1426. https://doi.org/10.1111/ced.14777

Clinical Outcomes Following Tocilizumab Administration in Mechanically Ventilated Coronavirus Disease 2019 Patients
Sirimaturos, M, Gotur, DB, Patel, SJ, Dreucean, D, Jakowenko, N, Cooper, MH, Brahmbhatt, N, Graviss, EA, Nguyen, DT, Pingali, SR, Lin, J & Musick, WL 2020, , Critical care explorations, vol. 2, no. 10, pp. e0232. https://doi.org/10.1097/CCE.0000000000000232

Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors
Anand, K, Sahu, G, Burns, E, Ensor, A, Ensor, J, Pingali, SR, Subbiah, V & Iyer, SP 2020, , ESMO Open, vol. 5, no. 4, e000866. https://doi.org/10.1136/esmoopen-2020-000866

Recurrent small bowel obstruction caused by Burkitt lymphoma in an elderly man: A case report and review of the literature
Kasparian, S, Burns, E, Shehabeldin, A, Awar, M & Pingali, SR 2020, , Journal of Medical Case Reports, vol. 14, no. 1, 127. https://doi.org/10.1186/s13256-020-02449-y

Radiation therapy in primary mediastinal large B-cell lymphoma treated with DA-R-EPOCH
Gentille, C, Anand, K, Dalwadi, S, Puri, A, Farach, A & Pingali, SR 2020, , Clinical Case Reports, vol. 8, no. 7, pp. 1153-1155. https://doi.org/10.1002/ccr3.2853

MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma
Wang, Q, Zhao, D, Xian, M, Wang, Z, Bi, E, Su, P, Qian, J, Ma, X, Yang, M, Liu, L, Zu, Y, Pingali, SR, Chen, K, Cai, Z & Yi, Q 2020, , Blood, vol. 136, no. 22, pp. 2557-2573. https://doi.org/10.1182/blood.2020005795

T-cell lymphoma secondary to checkpoint inhibitor therapy
Anand, K, Ensor, Jr. JE, Pingali, SR, Hwu, P, Duvic, M, Chiang, S, Miranda, R, Zu, Y & Iyer, S 2020, , Journal for immunotherapy of cancer, vol. 8, no. 1, e000104. https://doi.org/10.1136/jitc-2019-000104

Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review
Anand, K, Burns, EA, Ensor, J, Rice, L & Pingali, SR 2020, , Clinical Lymphoma, Myeloma and Leukemia, vol. 20, no. 1, pp. 18-23. https://doi.org/10.1016/j.clml.2019.08.008

The development of T-cell malignancies in patients with pre-existing myeloproliferative neoplasms: A report of three cases
Burns, EA, Anand, K, Chung, B, Shah, S, Randhawa, JK & Pingali, SR 2020, , ecancermedicalscience, vol. 14, 1011. https://doi.org/10.3332/ECANCER.2020.1011

Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated with Increased Mortality after Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study
Papanicolaou, GA, Ustun, C, Young, JAH, Chen, M, Kim, S, Woo Ahn, K, Komanduri, K, Lindemans, C, Auletta, JJ, Riches, ML, Abdel-Azim, H, Ahmed, IA, Aljurf, M, Antin, J, Ballen, KK, Beitinjaneh, A, Brown, VI, Cerny, J, Champlin, R, Chao, N, Chhabra, S, Dahi, PB, Daly, A, Dandoy, C, Dvorak, CC, Forman, S, Ganguly, S, Hashmi, SK, Kharfan-Dabaja, MA, Lazarus, H, Ljungman, P, Malone, AK, Murthy, G, Nishihori, T, Page, K, Pingali, RSR, Reddy, V, Saad, A, Savani, BN, Seftel, M, Szer, J, Vij, R, Weisdorf, D, William, BM, Williams, K, Wirk, B & Yared, J 2019, , Clinical Infectious Diseases, vol. 69, no. 10, pp. 1771-1779. https://doi.org/10.1093/cid/ciz031

Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT
Inamoto, Y, Petricek, I, Burns, L, Chhabra, S, DeFilipp, Z, Hematti, P, Rovó, A, Schears, R, Shah, A, Agrawal, V, Al-Khinji, A, Ahmed, I, Ali, A, Aljurf, M, Alkhateeb, H, Beitinjaneh, A, Bhatt, N, Buchbinder, D, Byrne, M, Callander, N, Fahnehjelm, K, Farhadfar, N, Gale, RP, Ganguly, S, Hildebrandt, GC, Horn, E, Jakubowski, A, Kamble, RT, Law, J, Lee, C, Nathan, S, Penack, O, Pingali, R, Prasad, P, Pulanic, D, Rotz, S, Shreenivas, A, Steinberg, A, Tabbara, K, Tichelli, A, Wirk, B, Yared, J, Basak, GW, Battiwalla, M, Duarte, R, Savani, BN, Flowers, MED, Shaw, BE & Valdés-Sanz, N 2019, , Bone Marrow Transplantation, vol. 54, no. 5, pp. 648-661. https://doi.org/10.1038/s41409-018-0339-6

Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation
Inamoto, Y, Petricek, I, Burns, L, Chhabra, S, DeFilipp, Z, Hematti, P, Rovó, A, Schears, R, Shah, A, Agrawal, V, Ahmed, A, Ahmed, I, Ali, A, Aljurf, M, Alkhateeb, H, Beitinjaneh, A, Bhatt, N, Buchbinder, D, Byrne, M, Callander, N, Fahnehjelm, K, Farhadfar, N, Gale, RP, Ganguly, S, Hashmi, S, Hildebrandt, GC, Horn, E, Jakubowski, A, Kamble, RT, Law, J, Lee, C, Nathan, S, Penack, O, Pingali, R, Prasad, P, Pulanic, D, Rotz, S, Shreenivas, A, Steinberg, A, Tabbara, K, Tichelli, A, Wirk, B, Yared, J, Basak, GW, Battiwalla, M, Duarte, R, Savani, BN, Flowers, MED, Shaw, BE & Valdés-Sanz, N 2019, , Biology of Blood and Marrow Transplantation, vol. 25, no. 5, pp. e145-e154. https://doi.org/10.1016/j.bbmt.2018.11.033

Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT (Bone Marrow Transplantation, (2019), 54, 5, (648-661), 10.1038/s41409-018-0339-6)
Inamoto, Y, Petricek, I, Burns, L, Chhabra, S, DeFilipp, Z, Hematti, P, Rovó, A, Schears, R, Shah, A, Agrawal, V, Al-Khinji, A, Ahmed, I, Ali, A, Aljurf, M, Alkhateeb, H, Beitinjaneh, A, Bhatt, N, Buchbinder, D, Byrne, M, Callander, N, Fahnehjelm, K, Farhadfar, N, Gale, RP, Ganguly, S, Hildebrandt, GC, Horn, E, Jakubowski, A, Kamble, RT, Law, J, Lee, C, Nathan, S, Penack, O, Pingali, R, Prasad, P, Pulanic, D, Rotz, S, Shreenivas, A, Steinberg, A, Tabbara, K, Tichelli, A, Wirk, B, Yared, J, Basak, GW, Battiwalla, M, Duarte, R, Savani, BN, Flowers, MED, Shaw, BE & Valdés-Sanz, N 2019, , Bone Marrow Transplantation, vol. 54, no. 5, pp. 782-783. https://doi.org/10.1038/s41409-019-0472-x

A new case of adult Acute Myeloid Leukemia with t(3;3)(p24;q26)
Yuan, B, Smith, J, Ewton, AA, Pingali, SR, Zieske, AW & Breman, A 2019, , Atlas of Genetics and Cytogenetics in Oncology and Haematology, vol. 23, no. 7, pp. 204-206. https://doi.org/10.4267/2042/70473

Acute myeloid leukemia with eosinophilia after cyclin-dependent kinases 4/6 inhibitor treatment due to underlying clonal hematopoiesis of indeterminate potential
Anand, K, Kumar, P, Pingali, SR, Pati, D & Iyer, SP 2019, , American Journal of Hematology, vol. 94, no. 3, pp. E82-E85. https://doi.org/10.1002/ajh.25380

Donor NKG2C copy number: An independent predictor for CMV Reactivation after double cord blood transplantation
Cao, K, Marin, D, Sekine, T, Rondon, G, Zhao, W, Smith, NT, Daher, M, Wang, Q, Li, L, Saliba, RM, Pingali, R, Popat, U, Hosing, C, Olson, A, Oran, B, Basar, R, Mehta, RS, Champlin, R, Shpall, EJ & Rezvani, K 2018, , Frontiers in immunology, vol. 9, no. OCT, 2444. https://doi.org/10.3389/fimmu.2018.02444

Use of PEG-asparaginase in a case of Hepatosplenic ?d T-cell lymphoma with long-term remission after stem cell transplantation
Sun, K, Sanchez, CG, Pingali, SR & Iyer, S 2018, , ecancermedicalscience, vol. 12, 872. https://doi.org/10.3332/ecancer.2018.872

Complete Local and Abscopal Responses from a Combination of Radiation and Nivolumab in Refractory Hodgkin's Lymphoma
Qin, Q, Nan, X, Miller, T, Fisher, R, Teh, B, Pandita, S, Farach, AM, Pingali, SR, Pandita, RK, Butler, EB, Pandita, TK & Iyer, SP 2018, , Radiation Research, vol. 190, no. 3, pp. 322-329. https://doi.org/10.1667/RR15048.1